North Elam Ambulatory Surgery Center, LLC
Raised
$867K
Investors
12
Min Invest
None stated
AltStreet Analysis
·Generated from EDGAR primary sources
North Elam Ambulatory Surgery Center, LLC is a North Carolina-based entity that filed a Form D for a 506(b) exempt offering of equity securities, reporting $867,000 raised from 12 investors. No minimum investment amount or first sale date was disclosed on the filing, and the entity does not appear to be part of a previously identified investment platform.
This filing falls into the alternative_investment category as a small, privately-placed equity offering under the 506(b) exemption, which is typical for closely-held operating entities like ambulatory surgery centers rather than pooled investment funds. The disclosed raise size ($867K) and investor count (12) are modest relative to institutional alternative investment vehicles, and no minimum investment tier was disclosed.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
Fund Family
Every vehicle in this manager's series as it appears on EDGAR, newest generation first. Sold-to-date and investor counts are each vehicle's latest Form D.
Fund family
North Elam Ambulatory Surgery Center1 vehicle · 0 generations · since 2026 · $2.7M sold across the family
| Vehicle | Role | First filed | Status | Sold | Investors |
|---|---|---|---|---|---|
| Unnumbered · first filed 2026-10-16 · 1 vehicle · $1.8M sold · 43 investors | |||||
| North Elam Ambulatory Surgery Center, LLCthis issuer | 2026-10-16 | raising | $1.8M | 43 | |
Grouped from Form D issuer names (generation, sleeve, jurisdiction and legal-form tokens removed); a name-only match, so abbreviated or renamed vehicles can be missed. Sold and investor figures are each vehicle's latest Form D; sleeves that report the same figure share one family-wide total and are counted once. Performance lines are what a public pension plan reports for its own interest in that fund, net, on the plan's cash flows and valuation date; they are not the general partner's figures.
In the Terminal
Filing events
2
latest Oct 16, 2026
Critical / warning
0 / 0
0 watch · 2 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
2
raising, closed
Latest event New filer · Oct 16, 2026
SEC.govInvestor
- 2 filing events with values and deltas, latest 2026-10-16, and alerts on the next one
- 2 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Deno Adkins
Director · Birmingham, AL
Eugene Bell
Director · Birmingham, AL
Shawn Clarke
Executive Officer, Director · Birmingham, AL
Thomas Cornett
Director · Birmingham, AL
Matthew Gay
Director · Birmingham, AL
Preston Hammock
Executive Officer, Director · Birmingham, AL
Nicole Tate
Director · Birmingham, AL
Christopher White
Director · Birmingham, AL
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
SCA Development, LLCCRD 35451 on BrokerCheck
Associated broker-dealer: None · Birmingham, AL
Questions About North Elam Ambulatory Surgery Center, LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is North Elam Ambulatory Surgery Center, LLC?
North Elam Ambulatory Surgery Center, LLC is a North Carolina limited liability company that filed a Form D with the SEC on October 16, 2026 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.
Is North Elam Ambulatory Surgery Center, LLC legit?
AltStreet does not rate legitimacy; it reports the public record. North Elam Ambulatory Surgery Center, LLC filed a Form D with the SEC on October 16, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $1,827,935 sold to 43 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is North Elam Ambulatory Surgery Center, LLC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that North Elam Ambulatory Surgery Center, LLC claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has North Elam Ambulatory Surgery Center, LLC raised?
North Elam Ambulatory Surgery Center, LLC reported $1,827,935 sold from 43 investors of a $2,695,000 total offering as of the Form D filed October 16, 2026.
Who can invest in North Elam Ambulatory Surgery Center, LLC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in North Elam Ambulatory Surgery Center, LLC?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling North Elam Ambulatory Surgery Center, LLC and how are they paid?
The Form D names SCA Development, LLC (CRD 35451), associated with None as the recipient of sales compensation. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind North Elam Ambulatory Surgery Center, LLC?
The Form D lists 8 related persons: Deno Adkins, director; Eugene Bell, director; Shawn Clarke, executive officer, director; Thomas Cornett, director; Matthew Gay, director; Preston Hammock, executive officer, director; Nicole Tate, director; Christopher White, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is North Elam Ambulatory Surgery Center, LLC located?
The issuer's address on its SEC filings is 509 N. Elam Avenue, Greensboro, NC 27403-1129. Its phone number of record is (205) 545-2736. It is organized under the laws of North Carolina.
How long is the North Elam Ambulatory Surgery Center, LLC offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
What is North Elam Ambulatory Surgery Center, LLC's revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.